Recovery from the lethal effects of saxitoxin: a therapeutic window for4-aminopyridine (4-AP)

Benton, B. J., Spriggs, D. L., Capacio, B. R., Chang, F.-C. T. (1995) 4-Aminopyridine antagonizes the lethal effects of saxitoxin (STX) and tetrodotoxin (TTX). International Society of Toxicology, 5th Pan American Symposium on Animal, Plant and Microbial Toxins, p. 217. Frederick, MD. July/August 1995 Capacio, B. R., Chang, F.-C. T., Spriggs, D., Byers, C. E., Matthews, R. L. and Benton, B. J. (1996) Pharmacokinetics and Electrophysiological Effects of 4-Aminopyridine in Awake Guinea Pigs. Proceedings of the 1996 Medical Defense Bioscience Review, U.S. Army Medical Research Institute of Chemical Defense, Vol. III, pp. 1466–1475. Aberdeen Proving Ground, MD Chang, 1989, A procedure for chronic recording of diaphragmatic electromyographic activity, Brain Res. Bull, 22, 561, 10.1016/0361-9230(89)90112-3 Chang, 1993, Central and peripheral cardio-respiratory effects of saxitoxin (STX) in urethane-anesthetized guinea-pigs, Toxicon., 31, 645, 10.1016/0041-0101(93)90119-4 Chang, 1996, 4-Aminopyridine antagonizes saxitoxin (STX) and tetrodotoxin (TTX) induced cardiorespiratory depression, Toxicon., 34, 671, 10.1016/0041-0101(95)00167-0 Chang, F.-C. T., Spriggs, D. L., Benton, B. J., Keller, S. A. and Capacio, B. R. (1997) 4-Aminopyridine Reverses Saxitoxin (STX) and Tetrodotoxin (TTX) Induced Cardiorespiratory Depression in Chronically Instrumented Guinea Pigs. Fundam. Appl. Toxicol. 38, 75--88 Childers, D. G. (1978) Modern Spectrum Analysis. IEEE Press, New York Folgering, 1979, Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine, Pflügers Arch., 379, 181, 10.1007/BF00586945 Glover, 1981, Cholinergic effect of 4-aminopyridine and adrenergic effect of 4-methyl-2-aminopyridine in cardiac muscles, Europ. J. Pharmac., 71, 21, 10.1016/0014-2999(81)90383-6 Kao, 1972, Pharmacology of tetrodotoxin and saxitoxin, Fed. Proc., 31, 1117 Lundh, 1977, 4-Aminopyridine, a new drug tested in the treatment of Eaton–Lambert syndrome, J. Neurol. Neurosurg. Psychiatry, 40, 1109, 10.1136/jnnp.40.11.1109 Lundh, 1979, Effects of 4-aminopyridine in myasthenia gravis, J. Neurol. Neurosurg. Psychiatry, 42, 171, 10.1136/jnnp.42.2.171 Murray, 1981, Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission, Neurology, 31, 264, 10.1212/WNL.31.3.265 Murtha, 1960, Pharmacological study of poisons from shellfish and puffer fish, Ann. N.Y. Acad. Sci., 90, 820, 10.1111/j.1749-6632.1960.tb26425.x Narahashi, 1972, Mechanism of action of tetrodotoxin and saxitoxin on excitable membranes, Fed. Proced., 31, 1124 Rutecki, 1987, 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition, J. Neurophysiol., 57, 1911, 10.1152/jn.1987.57.6.1911 Sutherland, S. K. (1983) Australian Animal Toxins. Oxford University Press, Melbourne Thesleff, 1980, Aminopyridines and synaptic transmission, Neuroscience, 5, 1413, 10.1016/0306-4522(80)90002-0 Van Diemen, 1993, Clinical Neuropharmacology, 16, 195, 10.1097/00002826-199306000-00002 Yanagisawa, 1979, Positive inotropic effect of 4-aminopyridine on dog ventricular muscle, Naunyn–Schmiedeberg's Arch. Pharmacol., 307, 207, 10.1007/BF00505935 Yeh, 1976, Interactions of aminopyridines with potassium channels of squid axon membranes, Biophys. J., 16, 77, 10.1016/S0006-3495(76)85663-9